The revenue stands at ₹8,645.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.35 per cent from ₹8,285.70 crore. This corresponds to a year-on-year *(YoY) growth of 8.36 per cent.
Operating Profit stands at ₹280.78 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.10 per cent from ₹217.49 crore. This corresponds to a year-on-year *(YoY) growth of 1.23 per cent.
PBDT stands at ₹893.45 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.26 per cent from ₹856.98 crore. This corresponds to a year-on-year *(YoY) growth of 15.61 per cent.
Profit Before Tax stands at ₹1,338.52 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.91 per cent from ₹1,275.92 crore. This corresponds to a year-on-year *(YoY) growth of 11.56 per cent.
Net Profit stands at ₹975.62 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.99 per cent from ₹848.45 crore. This represents a 15.35 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Aurobindo Pharma | -0.84% | 1.18% | 0.34% | -5.01% | 7.42% | 3.07% |
| Lupin | -0.77% | 0.62% | 2.09% | 9.81% | 12.99% | 12.48% |
| Zydus Lifesci. | 0.36% | -1.17% | 3.29% | -2.19% | -7.98% | 2.09% |
| Mankind Pharma | 0.35% | -0.33% | -2.16% | -6.80% | -16.84% | -12.34% |
| Alkem Lab | 0.42% | -6.74% | -4.85% | -4.70% | 1.37% | 15.20% |
| Biocon | -0.18% | 0.95% | 0.74% | -7.58% | 4.07% | 12.50% |
| Glenmark Pharma. | -0.13% | -0.45% | 1.73% | 10.04% | 4.06% | 47.87% |
Vice Chairman & Managing Director : Kambam Nityananda Reddy
Whole-time Director : M Madan Mohan Reddy
Non Executive Director : P V Ramprasad Reddy
Independent Director : Girish Paman Vanvari
Non Executive Director : P Sarath Chandra Reddy
Independent Director : Santanu Mukherjee
Chairman & Independent Director : M R Kumar
Non Executive Director : Satakarni Makkapati
Company Sec. & Compli. Officer : B Adi Reddy
Additional Director : Punita Kumar Sinha